These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 22151005

  • 1. Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism.
    Peacey SR, Wright D, Aye M, Moisey R.
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):94-8. PubMed ID: 22151005
    [Abstract] [Full Text] [Related]

  • 2. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A, Liew A, Finucane F, Baker L, O'Kelly P, Tormey W, Thompson CJ.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [Abstract] [Full Text] [Related]

  • 3. Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.
    Behan LA, Rogers B, Hannon MJ, O'Kelly P, Tormey W, Smith D, Thompson CJ, Agha A.
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):505-13. PubMed ID: 21521342
    [Abstract] [Full Text] [Related]

  • 4. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
    Behan LA, Kelleher G, Hannon MJ, Brady JJ, Rogers B, Tormey W, Smith D, Thompson CJ, McKenna MJ, Agha A.
    Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
    [Abstract] [Full Text] [Related]

  • 5. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
    Petersons CJ, Mangelsdorf BL, Thompson CH, Burt MG.
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2269-76. PubMed ID: 24606100
    [Abstract] [Full Text] [Related]

  • 6. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M.
    Exp Clin Endocrinol Diabetes; 2000 Jun; 108(7):486-92. PubMed ID: 11083070
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism.
    Ragnarsson O, Nyström HF, Johannsson G.
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):246-52. PubMed ID: 21767286
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.
    Dullaart RP, Schols JL, van der Steege G, Zelissen PM, Sluiter WJ, van Beek AP.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):359-66. PubMed ID: 18221399
    [Abstract] [Full Text] [Related]

  • 10. Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency.
    Maguire AM, Ambler GR, Moore B, McLean M, Falleti MG, Cowell CT.
    Pediatrics; 2007 Jul; 120(1):e164-71. PubMed ID: 17576782
    [Abstract] [Full Text] [Related]

  • 11. Acute effects of glucocorticoids on endothelial fibrinolytic and vasodilator function in humans.
    Dover AR, Hadoke PW, Walker BR, Newby DE.
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):321-6. PubMed ID: 17878762
    [Abstract] [Full Text] [Related]

  • 12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
    Ambrosi B, Sartorio A, Pizzocaro A, Passini E, Bottasso B, Federici A.
    Exp Clin Endocrinol Diabetes; 2000 Dec 22; 108(4):294-8. PubMed ID: 10961361
    [Abstract] [Full Text] [Related]

  • 14. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr 22; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 15. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 22; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 16. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF, Monson JP.
    Clin Endocrinol (Oxf); 2003 Nov 22; 59(5):613-20. PubMed ID: 14616886
    [Abstract] [Full Text] [Related]

  • 17. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
    Koh KK, Mincemoyer R, Bui MN, Csako G, Pucino F, Guetta V, Waclawiw M, Cannon RO.
    N Engl J Med; 1997 Mar 06; 336(10):683-90. PubMed ID: 9041098
    [Abstract] [Full Text] [Related]

  • 18. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.
    DeVile CJ, Stanhope R.
    Clin Endocrinol (Oxf); 1997 Jul 06; 47(1):37-41. PubMed ID: 9302370
    [Abstract] [Full Text] [Related]

  • 19. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ, O'Keane V, Miell JP.
    Psychoneuroendocrinology; 2004 Jul 06; 29(6):724-32. PubMed ID: 15110921
    [Abstract] [Full Text] [Related]

  • 20. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis.
    Mukherjee A, Murray RD, Columb B, Gleeson HK, Shalet SM.
    Clin Endocrinol (Oxf); 2003 Dec 06; 59(6):743-8. PubMed ID: 14974916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.